Company details

About

Asarina Pharma is the first company to have developed and synthesized Sepranolone as a medication, patenting a pharmaceutical formulation in 2010. Sepranolone has achieved an excellent safety profile in substantial clinical trials and is currently being run in a study for Menstrual Migraine. It will be tested in a Tourette syndrome study in 2021.

icon

Number of employees

1 - 10

icon

Main industry

Biotechnology

icon

Industry tags

icon

Founded in

2006

icon

Headquarters

Solna

icon

Country

Sweden

Sign up to uncover company details

5 free credit every month

Employee contacts

Name

Job Title

Email

Phone

Reach Decision Makers
at Asarina Pharma

5 Free credits every month!

Sign up now to uncover all the contact details